Science Current Events | Science News | Brightsurf.com
 

Wild gorillas carriers of a SIV virus close to the AIDS virus

November 14, 2006

In 2005, 40.3 million people in the world, including 25.8 million in Sub-Saharan Africa, were living with HIV. The question of the origin of HIV-1, responsible for the AIDS pandemic, has been stimulating the scientific community for many years.

Some months ago, the team of Martine Peeters, director of research at IRD, and Eric Delaporte, director of the mixed research unit UMR 145 jointly involving the IRD and the University of Montpellier 1, showed the chimpanzee subspecies living in the Congo Basin (2) to be the reservoir of HIV-1 virus group M, the source of the world pandemic and that of another, very rare variant, HIV-1 group N. However, the reservoir of the third HIV-1 group, group O which infects humans (3), remained unidentified up to now.

This team announces, in an article in the journal Nature, the discovery of a simian immunodeficiency virus (SIV) infection in wild gorillas. Samples of faeces collected from different communities of gorillas found in the remotest areas of the Cameroon tropical forest were found to contain antibodies against this virus, called SIVgor. The genetic characteristics of the virus were present again in three gorillas living more than 400 km apart. Phylogenetic analysis of SIVgor showed it to be related to HIV-1 group O found in humans, essentially in Cameroon and in neighbouring countries.

This discovery of an HIV-1 related virus in wild gorillas does not, however, call into question the fact that chimpanzees are the primary reservoir of SIV/HIV viruses that crop up again in gorillas and in humans. As Martine Peeters of the IRD says, "the viruses of groups M and N are, very clearly, the consequence of inter-species transmission from chimpanzee to humans, whereas the origin of HIV-1 group O is less apparent. It cannot be excluded that chimpanzees infected by HIV-1 group O might have contaminated humans and the gorilla independently, or that the gorilla, having been contaminated by the chimpanzee, might have contaminated humans".

This work thus opens up a Pandora's box on the questions and speculations concerning the ability of these viruses to cross over from one species to another. The main challenges facing these teams for future work will be determination of the prevalence, the geographical distribution and biology of SIV infections in these great apes, not forgetting the question of how the gorillas were contaminated. This last point remains a mystery,considered as rare.

1. UMR 145: Fran Van Heuverswijn, Cecile Neel, Florian Liegeois, Christelle Butel, Eric Delaporte and Martine Peeters jointly involving the IRD and the University of Montpellier1 University of Alabama (Beatrice Hahn and her colleagues), University of Nottingham (Paul Sharp and his colleagues) PRESICA Project of Cameroon headed by Eitel Mpoudi-Ngole.

2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngole E, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 2006 , 313 : 523-6

3. Scientists have known for a long time that the Aids virus shows a very strong genetic variability. Two main types of the virus exist: HIV 1 and HIV 2. HIV 1, the most widely spread in the world, embraces three groups (M, N,O) which manifest different genetic characteristics. Within group M, the most frequent, still 9 further subtypes can be distinguished (A, B, C, D, F, G, H, J, K), genetically close yet distinct.

Institut de Recherche Pour le Développement


Related Hiv-1 Current Events and Hiv-1 News Articles


Pursuing the destruction of HIV-infected cells
An oral drug used to treat an illness unrelated to HIV eradicated infectious HIV-producing cells in lab cultures while sparing uninfected cells - and suppressed the virus in patients during treatment and for at least eight weeks after the drug was stopped, according to results of a clinical pilot trial and researchers at Rutgers University and Dartmouth College.

HIV vaccine design should adapt as HIV virus mutates
Human immunodeficiency virus is known to be a highly variable virus that adapts to a person's immune response during the lifetime infection, and a new study published in Nature Medicine shows that viral adaptation in HIV can predict a person's current disease status, as well as the degree to which newly transmitted HIV-1 is adapted to their new host.

Findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial
Some people infected with HIV naturally produce antibodies that effectively neutralize many strains of the rapidly mutating virus, and scientists are working to develop a vaccine capable of inducing such "broadly neutralizing" antibodies that can prevent HIV infection.

Osel scientists engineer vaginal lactobacillus to express neutralizing HIV-1 antibody fragments
A normal, predominant bacterial species of the healthy vaginal microbiota can be engineered for potential use as a novel protective agent against HIV-1 transmission in women, according to a new publication from scientists at Osel, Inc. and their collaborators.

Temple scientists eliminate HIV-1 from genome of human T-Cells
A specialized gene editing system designed by scientists at the Lewis Katz School of Medicine at Temple University is paving the way to an eventual cure for patients infected with HIV, the virus that causes AIDS.

New research could help improve HIV/AIDS therapies
Hideki Aihara, Zhiqi Yin, and Ke Shi of the University of Minnesota, along with colleagues from Cornell University and St. Louis University have made a major stride in exploring new therapies to combat HIV/AIDS and retrovirus-based cancers.

Progress toward an HIV cure highlighted in special issue of AIDS Research and Human Retroviruses
A cure for HIV/AIDS is the ultimate goal of rapidly advancing research involving diverse and innovative approaches.

Effects on HIV and Ebola
Scientists at the Helmholtz Zentrum München discover that extracts of the medicinal plant Cistus incanus (Ci) prevent human immunodeficiency viruses from infecting cells.

Adenosine deaminase may help the immune system fight HIV on its own
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.

Neural networks adapt to the presence of a toxic HIV protein
Nearly half of HIV infected patients suffer from impaired neurocognitive function. The HIV protein transactivator of transcription (Tat) is an important contributor to HIV neuropathogenesis because it is a potent neurotoxin that continues to be produced despite treatment with antiretroviral therapy.
More Hiv-1 Current Events and Hiv-1 News Articles

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)
by imstilljosh.com


Learning you are HIV-positive is a pretty scary time in a person's life. Josh Robbins found out that he was living with HIV in the beginning of 2012 and started an online journey encouraging others that are living with the virus to keep their mind and spirit in a good place. His main method of offering that encouragement? By sharing images. This coffee-table formatted book shares the images that Josh Robbins of imstilljosh.com uses to fight HIV stigma.

A Clinical Guide to Pediatric HIV: Bridging the Gaps Between Research and Practice

A Clinical Guide to Pediatric HIV: Bridging the Gaps Between Research and Practice
by Tiffany Chenneville (Editor)


This book examines the impact of pediatric HIV on children, adolescents, and their families. Beginning with an overview of pediatric HIV epidemiology, it traces the medical, psychological, and social dimensions of HIV through the trajectory of childhood and youth. It examines the latest research on a wide range of topics, including treatment adherence, cultural, legal, and ethical issues, and HIV stigma and its reduction. Chapters offer expert recommendations for clinicians working with children with HIV as well as researchers studying pediatric HIV. In addition, the book also discusses daily concerns associated with pediatric HIV, such as disease management, coping, access to services, risk prevention, and health promotion. 
Topics featured in this book include: The impact of...

HIV/AIDS in China: Beyond the Numbers (Public Health in China)

HIV/AIDS in China: Beyond the Numbers (Public Health in China)
by Zunyou Wu (Editor)


This book presents the history of HIV/AIDS in China, which over the last three decades has been a gripping tale of exclusion and fear, and then, by turns, of involuntary tragedy, cautious experimentation and finally vigorous response. It discusses the occurrence, development and epidemic studies and also introduces China’s policies and measures to conquer this epidemic, offering readers valuable insights into China’s approach to prevention in this field.


AIDS HIV (ACRN and AACRN) Certification Review (Certification in HIV Nursing Book 1)

AIDS HIV (ACRN and AACRN) Certification Review (Certification in HIV Nursing Book 1)
by Knowledge Testing, Inc.


AIDS Certified Registered Nurse (ACRN) and Advanced AIDS Certified Registered Nurse (AACRN) Certification Review, 600 multiple choice questions.

Provides key information you need to know to pass the board and certification exam.

All questions have explanations with keywords linked to additional online references.

Correct answer is on the next page after the question with explanations and links to further research the key point(s) covered in each question.

HIV/AIDS: A Very Short Introduction (Very Short Introductions)

HIV/AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)


HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means...

Taking Turns: Stories from HIV/AIDS Care Unit 371 (Graphic Medicine)

Taking Turns: Stories from HIV/AIDS Care Unit 371 (Graphic Medicine)
by MK Czerwiec (Author)


In 1994, at the height of the AIDS epidemic in the United States, MK Czerwiec took her first nursing job, at Illinois Masonic Medical Center in Chicago, as part of the caregiving staff of HIV/AIDS Care Unit 371. Taking Turns pulls back the curtain on life in the ward.A shining example of excellence in the treatment and care of patients, Unit 371 was a community for thousands of patients and families affected by HIV and AIDS and the people who cared for them. This graphic novel combines Czerwiec’s memories with the oral histories of patients, family members, and staff. It depicts life and death in the ward, the ways the unit affected and informed those who passed through it, and how many look back on their time there today. Czerwiec joined Unit 371 at a pivotal time in the history of...

How-to Stop HIV Before it Stops You!: Check out PrEP and PEP one pill a day treatments before you get HIV!

How-to Stop HIV Before it Stops You!: Check out PrEP and PEP one pill a day treatments before you get HIV!


This little guide is for and about taking a proactive stance in not getting HIV /AIDS with the advanced treatment option known as PrEP, Pre-Exposure Prophylaxis. It also includes some information about emergency treatment for one time exposure to HIV called PEP.
Inside the book you will find the following:
What is PrEP?
Definition
The drug
How it works
Limitations
Approval
Video
Who is PrEP it for
HIV negative
Women Bisexual Straight
Men Gay Bisexual Heterosexual
Transgender and gender non-conforming
Injecting drug users
Serodiscordant mixed status couples
How to get PrEP
Doctors
Pharmacy
When
How to use it
Cost
How much is that doggy in the window?
Low income no...

HIV, AIDS and Childbearing: Public Policy, Private Lives

HIV, AIDS and Childbearing: Public Policy, Private Lives
by Ruth R. Faden (Editor), Nancy E. Kass (Editor)


Whether, with whom, and when to have children are among the most precious of our private decisions. Increasingly, however, the interest of others in these decisions raise difficult questions about the role of government and health professionals in influencing reproductive choice. Nowhere is this tension felt more keenly than in the context of HIV and AIDS. This book takes on the tough issues related to HIV and childbearing: Is there a moral right to have children? What are the limits of persuasion? Are there constitutional constraints on interference with reproduction? What are the precedents with restricting the childbearing behavior of women who use drugs? The book includes original work by doctors, lawyers, ethicists, and public health professionals. Also included are the...

Advances in HIV-1 Assembly and Release

Advances in HIV-1 Assembly and Release
by Eric O. Freed (Editor)


​Over the past decade, enormous progress has been made in understanding the late events in the HIV replication cycle.  This has been made possible by major advances in cell biology, virology, and structural biology.  The field continues to move forward rapidly, with important new discoveries being reported on a regular basis.  The impact of this progress across a broad spectrum of biomedical research has been substantial.  The increase in basic knowledge in the areas of HIV assembly, release, and maturation has been accompanied by new possibilities for therapeutic intervention.The work includes topics relating to basic molecular biology, cell biology, and structural biology of HIV assembly, coupled with more applied ideas of how this basic information can inform the field of...

© 2017 BrightSurf.com